KELSIE CATO: Open Payments
NPI 1669706768 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,622 in 134 payments from 26 companies in 2025. Trend: 2023 $2,769 · 2024 $3,299 · 2025 $3,622
Food & beverage: $3,622
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $655 |
| Axsome Therapeutics, Inc. | 9 | $410 |
| PFIZER INC. | 16 | $408 |
| Averitas Pharma Inc. | 10 | $347 |
| Boston Scientific Corporation | 5 | $323 |
| Lundbeck LLC | 10 | $276 |
| UCB, Inc. | 9 | $205 |
| Eisai Inc. | 3 | $140 |
| Impel Pharmaceuticals LLC | 5 | $94 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
Products named: Symbravo, QUTENZA, NURTEC ODT, WaveWriter Alpha Prime 16, QULIPTA, UBRELVY, VYEPTI, LEQEMBI.
Industry payments across NC — which companies pay providers there.
